Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMI PLC Director's Dealing 2022

Mar 22, 2022

5257_dirs_2022-03-22_be53c3f5-3d26-4c30-81d9-8d34747f7c9d.html

Director's Dealing

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

National Storage Mechanism | Additional information

RNS Number : 6650F

IMI PLC

22 March 2022

22 March 2022

IMI plc

(the "Company")

Notification of Transaction by Person Discharging Managerial Responsibilities ("PDMRs") and Persons Closely Associated with them

This notification relates to transactions notified in accordance with the Market Abuse Regulation, further details below:

1. Details of the person discharging managerial responsibilities/person closely associated
a) Name Daniel Shook
2. Reason for the notification
a) Position/status Chief Financial Officer
b) Initial notification/ Amendment Initial Notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name IMI plc
b) LEI 2138002W9Q21PF751R30
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument



 Identification code
Ordinary share



 

GB00BGLP8L22
b) Nature of the transaction Exercise of Deferred Bonus Shares award in respect of 22,225 shares vesting under the IMI plc Incentive Plan (nil cost option).

Daniel Shook sold sufficient shares 10,470 arising from the exercise to cover costs, and retained the balance as shares.

Exercise of award in respect of 55,072 shares vesting under the IMI plc Incentive Plan (nil cost option).

Daniel Shook sold sufficient shares 25,943 arising from the exercise to cover costs, and retained the balance as shares.
c) Price(s) and volume(s) Price(s) Volume(s) sold
£14.825 36,413 40,884
d) Aggregated information

·      Aggregated volume exercised

·      No of shares retained

·      Price
77,297

40,884

£14.825
e) Date of the transaction 2022-03-21
f) Place of the transaction London Stock Exchange Main Market (XLON)

For further information, please contact:

Louise Waldek

Group General Counsel and Company Secretary

Telephone: 0121 717 3700

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHSEAFWEEESEED